IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study (2023)
Source: Kidney international reports. Unidade: FM
Subjects: NEFROPATIAS, PESQUISA QUALITATIVA, IMUNOGLOBULINAS
ABNT
BARRATT, Jonathan et al. IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study. Kidney international reports, v. 8, n. 5, p. 1043-1056, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53820. Acesso em: 24 ago. 2024.APA
Barratt, J., Rovin, B., Wong, M. G., Alpers, C. E., Bieler, S., He, P., et al. (2023). IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study. Kidney international reports, 8( 5), 1043-1056. doi:10.1016/j.ekir.2023.02.1086NLM
Barratt J, Rovin B, Wong MG, Alpers CE, Bieler S, He P, Inrig J, Komers R, Heerspink HJL, Mercer A, Noronha I de L. IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study [Internet]. Kidney international reports. 2023 ; 8( 5): 1043-1056.[citado 2024 ago. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53820Vancouver
Barratt J, Rovin B, Wong MG, Alpers CE, Bieler S, He P, Inrig J, Komers R, Heerspink HJL, Mercer A, Noronha I de L. IgA Nephropathy Patient Baseline Characteristics in the Sparsentan PROTECT Study [Internet]. Kidney international reports. 2023 ; 8( 5): 1043-1056.[citado 2024 ago. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53820